This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels
EU Pharmaceutical Law Forum 2024
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels

Tuesday 21 May 2024

Stay Ahead of the Curve in Business Transactions with the Latest Developments in Competition
Law, Patents & SPCs

Practical Advice, Cutting-Edge Guidance, and Actionable Strategies on Antitrust Challenges, Merger Control Cases, SPC Revisions, and FSR & UPC Developments

Dive In To Key Competition Law, SPC, and Patient Litigation Perspectives On:

Expert Insight from Antitrust Authorities

  • Exclusive insight on authority approach and review pharmaceutical merger control cases
  • Be armed for negotiations on discriminatory pricing, discounts and rebates
  • Analyze the legal fallout and changes needed in working practices from the Servier case

Practical Advice on Managing Antitrust Risk

  • Examine commercial implications of merger control activity
  • Avoid risk in information exchange between competitors
  • Gain visibility on how FSR is operating and how it will affect your organization  

Prepare for Changes to Patents & SPCs and Discover How:

  • EU-wide compulsory licensing instruments affect your Regulatory Data Protection
  • SPC revisions to patent protection in the EU Pharma package will impact your business
  • Litigation is being affected by the Unified Patent Court (UPC)